DK1572694T3 - Pyrrolo[2,1-c][1,4]benzodiazepiner som vasopressinagonister - Google Patents

Pyrrolo[2,1-c][1,4]benzodiazepiner som vasopressinagonister

Info

Publication number
DK1572694T3
DK1572694T3 DK03814820T DK03814820T DK1572694T3 DK 1572694 T3 DK1572694 T3 DK 1572694T3 DK 03814820 T DK03814820 T DK 03814820T DK 03814820 T DK03814820 T DK 03814820T DK 1572694 T3 DK1572694 T3 DK 1572694T3
Authority
DK
Denmark
Prior art keywords
benzodiazepines
pyrrolo
vasopressin agonists
vasopressin
agonists
Prior art date
Application number
DK03814820T
Other languages
Danish (da)
English (en)
Inventor
Albert J Molinari
Eugene J Trybulski
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK1572694T3 publication Critical patent/DK1572694T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
DK03814820T 2002-12-16 2003-12-16 Pyrrolo[2,1-c][1,4]benzodiazepiner som vasopressinagonister DK1572694T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/320,761 US7138393B2 (en) 1998-07-24 2002-12-16 Biologically active vasopressin agonist metabolites
PCT/US2003/039897 WO2004060894A1 (en) 2002-12-16 2003-12-16 Pyrrolo`2,1-c!`1,4! benzodiazepines as vasopressin agonists

Publications (1)

Publication Number Publication Date
DK1572694T3 true DK1572694T3 (da) 2009-02-02

Family

ID=32710746

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03814820T DK1572694T3 (da) 2002-12-16 2003-12-16 Pyrrolo[2,1-c][1,4]benzodiazepiner som vasopressinagonister

Country Status (15)

Country Link
US (1) US7138393B2 (https=)
EP (1) EP1572694B1 (https=)
JP (1) JP2006514956A (https=)
CN (1) CN1745083A (https=)
AR (1) AR042467A1 (https=)
AT (1) ATE410428T1 (https=)
AU (1) AU2003297127A1 (https=)
BR (1) BR0317383A (https=)
CA (1) CA2508764A1 (https=)
DE (1) DE60324018D1 (https=)
DK (1) DK1572694T3 (https=)
ES (1) ES2312859T3 (https=)
MX (1) MXPA05006241A (https=)
TW (1) TW200413355A (https=)
WO (1) WO2004060894A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
JP5451613B2 (ja) 2007-08-06 2014-03-26 アラーガン、インコーポレイテッド デスモプレシン薬物送達のための方法及びデバイス
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
NO3085381T3 (https=) * 2008-05-21 2018-09-15
KR101385433B1 (ko) 2008-11-18 2014-04-14 에프. 호프만-라 로슈 아게 다이하이드로테트라아자벤조아줄렌의 알킬사이클로헥실에터
US9532959B2 (en) 2010-07-08 2017-01-03 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for reducing frequency of urination and method of use thereof
US10010514B2 (en) 2010-07-08 2018-07-03 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for reducing frequency of urination and method of use thereof
MX2014008283A (es) * 2012-01-04 2015-03-03 Wellesley Pharmaceutical Llc Formulacion de liberacion prolongada para reducir la frecuencia de orinar y metodos de uso de esta.
BR112014016550A8 (pt) * 2012-01-04 2017-07-04 Wellesley Pharmaceuticals Llc formulação de liberação retardada para reduzir a frequência de urinação e método de uso da mesma
US10278925B2 (en) 2012-01-04 2019-05-07 Wellesley Pharmaceuticals, Llc Delayed-release formulations, methods of making and use thereof
US10105330B2 (en) 2012-01-04 2018-10-23 Wellesley Pharmaceuticals, Llc Extended, delayed and immediate release formulation method of manufacturing and use thereof
US10105328B2 (en) 2014-06-06 2018-10-23 Wellesley Pharmaceuticals, Llc Composition for reducing frequency of urination, method of making and use thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1251767B (de) * 1964-02-28 1968-04-18 Dr Karl Thomae Gesellschaft mit beschrankter Haftung Biberach/Riß Verfahren zur Herstellung von neuen m 6 Stellung substituierten 5 6 Dihydro-5oxo HH pyrido[2,3-b] [l,5]benzodiazepinen
US4680298A (en) 1983-05-31 1987-07-14 Schering Corporation Tricyclic anti-allergy and use as anti-inflammatory agents
US4766108A (en) * 1986-12-04 1988-08-23 Smith Kline Beckman Corporation Tyr-Arg-vasopressin antagonists
US5055448A (en) * 1987-06-25 1991-10-08 Medical College Of Ohio Linear derivatives of arginine vasopressin antagonists
US4839355A (en) 1987-09-09 1989-06-13 Sterling Drug Inc. Tricyclic-pyridinylquinoline compounds, their preparation and use
US5070187A (en) * 1989-11-03 1991-12-03 Trustees Of Boston University Pharmacologically effective antagonists of arginine-vasopressin
CA2048003A1 (en) 1990-08-21 1992-02-22 Serge Burner Tricyclic pyridone derivatives
US5516774A (en) 1993-07-29 1996-05-14 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
US5512563A (en) * 1993-07-29 1996-04-30 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
US5420270A (en) * 1993-10-07 1995-05-30 G. D. Searle & Co. Aryl substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
ES2199251T3 (es) 1994-06-15 2004-02-16 Otsuka Pharmaceutical Company, Limited Derivados benzoheterociclicos utilizables como moduladores de vasopresina o de oxitocina.
JPH0881460A (ja) 1994-09-08 1996-03-26 Yamanouchi Pharmaceut Co Ltd 新規なテトラヒドロベンゾジアゼピン誘導体又はその塩
US5536718A (en) * 1995-01-17 1996-07-16 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
US5521173A (en) * 1995-01-17 1996-05-28 American Home Products Corporation Tricyclic benzazepine vasopressin antagonists
AR002459A1 (es) 1995-01-17 1998-03-25 American Cyanamid Co Antagonistas de vasopresina de benzacepina triciclicos, una composicion farmaceutica que los contiene, un metodo para tratar enfermedades y unprocedimiento para su preparacion.
TW359669B (en) 1995-12-15 1999-06-01 Otsuka Pharma Co Ltd Benzazepine derivatives
US5880122A (en) * 1996-11-01 1999-03-09 American Home Products Corporation 3-Carboxamide derivatives of 5H-pyrrolo 2,1-c! 1,4!-benzodiazepines
AU727654B2 (en) 1997-06-13 2000-12-21 Yamanouchi Pharmaceutical Co., Ltd. Tricyclic pyrazole derivative
DE69826487T2 (de) 1997-07-30 2005-12-01 Wyeth Trizyclische vasopressin-agonisten
US6194407B1 (en) * 1997-07-30 2001-02-27 American Home Products Corporation Tricyclic pyrido vasopressin agonists
US6297234B1 (en) 1999-02-04 2001-10-02 American Home Products Corporation Arylthiophene vasopressin agonists
WO2000046228A2 (en) 1999-02-04 2000-08-10 American Home Products Corporation Pyrrolobenzodiazepine carboxyamide vasopressin agonists
CN1391476A (zh) 1999-09-27 2003-01-15 美国氰胺公司 血管升压素激动剂制剂和方法
CN1399542A (zh) 1999-09-27 2003-02-26 美国氰胺公司 药用载体制剂
GB0000079D0 (en) 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
GB0015601D0 (en) 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents

Also Published As

Publication number Publication date
CN1745083A (zh) 2006-03-08
JP2006514956A (ja) 2006-05-18
EP1572694B1 (en) 2008-10-08
WO2004060894A1 (en) 2004-07-22
US7138393B2 (en) 2006-11-21
DE60324018D1 (de) 2008-11-20
AR042467A1 (es) 2005-06-22
CA2508764A1 (en) 2004-07-22
AU2003297127A1 (en) 2004-07-29
ATE410428T1 (de) 2008-10-15
MXPA05006241A (es) 2005-08-19
US20030134845A1 (en) 2003-07-17
ES2312859T3 (es) 2009-03-01
TW200413355A (en) 2004-08-01
BR0317383A (pt) 2005-11-16
EP1572694A1 (en) 2005-09-14

Similar Documents

Publication Publication Date Title
AU2003283653A1 (en) Solution search
FR14C0066I2 (fr) 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles
NO20044654L (no) Piperidinoylpiperidiner som 5-HTIF-agonister
NO20031006D0 (no) Imidazolo-5-yl-2-anilino-pyrimidiner som midler for inhibering av celleproliferasjon
DK1379511T3 (da) Dihydro-benzo[b][1,4]diazepin-2-on-derivater som mGLuR2-antagonister II
DK1185529T3 (da) Pyrazolbenzodiazepiner som CDK2-inhibitorer
EG23416A (en) Detergent composition.
NO20034496L (no) Dihydro-benzo[b][1,4]diazepin-2-on-derivater som MGLUR2- antagonister I
DE602004021572D1 (de) SUBSTITUIERTE 8-PERFLUORO-6,7,8,9-TETRAHYDROPYRIMIDOi1,2-A PYRIMIDIN-4-ON-DERIVATE
ATE326467T1 (de) Imidazo 1,2-aöpyridine
AU2003266611A1 (en) Detergent composition
DK1572694T3 (da) Pyrrolo[2,1-c][1,4]benzodiazepiner som vasopressinagonister
NO20021251D0 (no) Tienoisoksazolyl- og tienylpyrrazolyl-fenoksysubstituerte propylderivater anvendelige som D4antagonister
AR028248A1 (es) Nuevos compuestos 2,3,4,5-tetrahidro-1h-(1,4) diazepino (1,7-a) indol
MX263097B (es) Inhibidores de entrada a moleculas pequenas.
AU2003202606A1 (en) Tub arrangement
AU2003236686A1 (en) 4,5-dihydro-imidazo(4,5,1-j) quinolin-6-ones as parp inhibitors
EP1486553A4 (en) NEW DEEPARAFFINING TOOL
AU2003300705A1 (en) C2-fluoro pyrrolo(2,1-c)(1,4)benzodiazepine dimers
AU2003218659A1 (en) Detergent composition
AU2003209495A1 (en) Bacteriophage composition
AU2003224130A1 (en) Benzoxazinone derivative
GB2398078B (en) Solvent
DK1380585T3 (da) Pyrazolopyridinon som mellemprodukt
AU2003283405A1 (en) Detergent composition